Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
6 pending office actions • 6 clients • 6 examiners • 5 art units • 0 of 6 (0%) have an AI response strategy ready
HelixIP LLP concentrates its practice in Biotechnology & Pharmaceuticals, with a record of 240 career applications. The firm has attained a resolved allowance rate of 73.39 percent, showing its results in navigating the requirements of biotech patent prosecution. This 73.39 percent resolved allowance rate provides a metric of the firm's performance in the life sciences sector.
The firm's average of 3.47 office actions per allowance indicates the examination process for its clients. There are 6 pending office actions currently being handled. The 240 career applications and the average of 3.47 office actions per allowance provide a picture of the firm's historical performance. With 6 pending office actions, the firm continues its work in the pharmaceutical and biotechnology fields.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (33%) |
| Multi-statute (no §101) | 4 (67%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| XING, CHRISTINA ILONA | 1 | 82.9% | +17.8% |
| JACOBSON, MICHELE LYNN | 1 | 28.0% | +32.9% |
| BERKE-SCHLESSEL, DAVID W | 1 | 66.7% | +31.8% |
| SPEED, DEQUANTARIUS JAVON | 1 | 70.0% | +69.2% |
| JONES-FOSTER, ERICA NICOLE | 1 | 48.1% | +44.7% |
| QIAN, CELINE X | 1 | 47.6% | +16.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18570546 | New Microbial Diamine Oxidase Derived from Yarrowia Lipolytica for the Degradation of Biogenic Amines | BERKE-SCHLESSEL, DAVID W | 5d |
| 19203667 | Optical Device for Monitoring the Silver Content of Thin Films | XING, CHRISTINA ILONA | — |
| 18644714 | Sugar-Free Edible Vessel | JACOBSON, MICHELE LYNN | — |
| 18558872 | Methods and Compositions for Improving Carbon Accumulation in Plants | SPEED, DEQUANTARIUS JAVON | — |
| 18260225 | Methods and Compositions for Making Amide Compounds | JONES-FOSTER, ERICA NICOLE | — |
| 18260220 | Methods and Compositions for Diagnosing and Treating Rare Genetic DIseases | QIAN, CELINE X | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18570546 | New Microbial Diamine Oxidase Derived from Yarrowia Lipolytica for the Degradation of Biogenic Amines | BERKE-SCHLESSEL, DAVID W | 5d |
| 19203667 | Optical Device for Monitoring the Silver Content of Thin Films | XING, CHRISTINA ILONA | — |
| 18644714 | Sugar-Free Edible Vessel | JACOBSON, MICHELE LYNN | — |
| 18558872 | Methods and Compositions for Improving Carbon Accumulation in Plants | SPEED, DEQUANTARIUS JAVON | — |
| 18260225 | Methods and Compositions for Making Amide Compounds | JONES-FOSTER, ERICA NICOLE | — |
| 18260220 | Methods and Compositions for Diagnosing and Treating Rare Genetic DIseases | QIAN, CELINE X | — |
| Client (Assignee) | Pending OAs |
|---|---|
| Silverpeutics, Inc. | 1 |
| Loliware, Inc. | 1 |
| UNIVERSITÄT HOHENHEIM | 1 |
| David BECKER | 1 |
| GENOMATICA, INC. | 1 |
| Rosebud Biosciences, Inc. | 1 |
| Art Unit | Apps |
|---|---|
| 1793 | 1 |
| 1651 | 1 |
| 1663 | 1 |
| 1656 | 1 |
| 1699 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19203667 | Optical Device for Monitoring the Silver Content of Thin Films | Silverpeutics, Inc. | XING, CHRISTINA ILONA | §103§112 | Non-Final OA | — | Pending | May 09, 2025 | |
| 18644714 | Sugar-Free Edible Vessel | Loliware, Inc. | JACOBSON, MICHELE LYNN | 1793 | §102§103 | Non-Final OA | — | Pending | Apr 24, 2024 |
| 18570546 | New Microbial Diamine Oxidase Derived from Yarrowia Lipolytica for the Degradation of Biogenic Amines | UNIVERSITÄT HOHENHEIM | BERKE-SCHLESSEL, DAVID W | 1651 | §101§103 | Final Rejection | 5d | Pending | Dec 14, 2023 |
| 18558872 | Methods and Compositions for Improving Carbon Accumulation in Plants | David Becker | SPEED, DEQUANTARIUS JAVON | 1663 | §102§103§112 | Non-Final OA | — | Pending | Nov 03, 2023 |
| 18260225 | Methods and Compositions for Making Amide Compounds | Genomatica, Inc. | JONES-FOSTER, ERICA NICOLE | 1656 | §103§112 | Final Rejection | — | Pending | Jun 30, 2023 |
| 18260220 | Methods and Compositions for Diagnosing and Treating Rare Genetic DIseases | Rosebud Biosciences, Inc. | QIAN, CELINE X | 1699 | §101§102§103§112 | Non-Final OA | — | Pending | Jun 30, 2023 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial